LEGN (Legend Biotech) Net Margin %: -17.80% (As of Mar. 2026)

What is Legend Biotech Net Margin %?

Legend Biotech LEGN -1.04% 73 Net Margin % is -17.80% as of Mar. 2026. GuruFocus rates LEGN with a GF Score™ of 73/100 and a GF Value™ of $98.47 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 947 Biotechnology companies, Legend Biotech ranks better than 62.09% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Legend Biotech's Net Income for the three months ended in Mar. 2026 was $-54 Mil. Legend Biotech's Revenue for the three months ended in Mar. 2026 was $305 Mil. Therefore, Legend Biotech's net margin for the quarter that ended in Mar. 2026 was -17.80%.

The historical rank and industry rank for Legend Biotech's Net Margin % or its related term are showing as below:

LEGN' s Net Margin % Range Over the Past 10 Years
Min: -586.38 Med: -207.01 Max: -5.67
Current: -21.97

LEGN's Net Margin % is ranked better than
62.09% of 947 companies
in the Biotechnology industry
Industry Median: -89.33 vs LEGN: -21.97

Legend Biotech (NAS:LEGN) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Legend Biotech Net Margin % Related Terms

Legend Biotech Net Margin % Historical Data

* Premium members only.

The historical data trend for Legend Biotech's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Legend Biotech Net Margin % Chart

Legend Biotech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Net Margin %

Get a 7-Day Free Trial

-586.38

-381.48

-181.80

-28.22

-28.85

Legend Biotech Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Net Margin %	Get a 7-Day Free Trial															-51.79	-49.16	-14.57	-10.06	-17.80

LEGN vs DNTH, XENE, CAI: Net Margin % Comparison

For the Biotechnology subindustry, Legend Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Legend Biotech Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Legend Biotech's Net Margin % distribution charts can be found below:

* The bar in red indicates where Legend Biotech's Net Margin % falls into.

Save Embed

73GF Score

Legend Biotech Corp LEGN

Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Legend Biotech Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Legend Biotech's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin	=	Net Income (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-296.8	/	1028.9
	=	-28.85 %

Legend Biotech's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin	=	Net Income (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-54.3	/	305.1
	=	-17.80 %

Frequently Asked Questions Learn more about Net Margin % →

What does a Net Margin % of -17.80% mean?

Legend Biotech (LEGN) has a Net Margin % of -17.80% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Legend Biotech and its competitors. According to the industry distribution chart, Legend Biotech ranks #359 out of 947 companies in the Biotechnology industry, placing it in the top 37.9%.

Is Legend Biotech's Net Margin % too high?

Legend Biotech's current Net Margin % is -17.80%. Based on the distribution chart, Legend Biotech ranks #359 out of 947 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Legend Biotech has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Legend Biotech's Net Margin % compare to DNTH and XENE?

According to the Biotechnology industry distribution chart, Legend Biotech ranks #359 out of 947 companies for Net Margin %. This puts Legend Biotech in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Net Margin % for a Biotechnology company?

A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Net Margin % mean?

A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Legend Biotech and its competitors. Legend Biotech's current Net Margin % is -17.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Legend Biotech stock overvalued right now?

Based on GuruFocus' analysis, Legend Biotech (LEGN) is currently considered Possible Value Trap. The stock's GF Value™ is $98.47, compared to a current price of $29.08 — trading 70.5% below its estimated fair value. The current Net Margin % is -17.80%. Legend Biotech's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Net Margin % calculated?

Net Margin % is calculated from a company's financial statements. For Legend Biotech (LEGN), the current Net Margin % is -17.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Legend Biotech (LEGN) Overvalued in 2026?

Based on GuruFocus' analysis, Legend Biotech stock appears to be undervalued. The current stock price of $29.08 is trading 70.5% below its estimated GF Value™ of $98.47. GuruFocus considers Legend Biotech to be Possible Value Trap.

Key valuation signals for LEGN:

Net Margin %: -17.80%
GF Value™: $98.47 vs. price of $29.08 (70.5% below fair value)
GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the LEGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Legend Biotech Business Description

Industry Healthcare Biotechnology

Comparable Companies DNTH XENE CAI CRSP LGND CGON TVTX TGTX MANE SRRK VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges 9LB:Germany

Address 2101 Cottontail Lane, Somerset, NJ, USA, 08873

Website https://www.legendbiotech.com

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

73GF Score

Get the complete analysis for LEGN

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.08

Price

$98.47

GF Value

View LEGN Analysis

See Net Margin % data for all stocks →